Van Eck Associates Corp Repligen Corp Transaction History

Van Eck Associates Corp

  • $78.1 Billion
  • Q4 2024

A detailed history of Van Eck Associates Corp transactions in Repligen Corp stock. As of the latest transaction made, Van Eck Associates Corp holds 42,226 shares of RGEN stock, worth $7.02 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
42,226
Previous 39,160 7.83%
Holding current value
$7.02 Million
Previous $5.38 Million 12.89%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 29, 2025
BUY
$123.41 - $160.92 $378,375 - $493,380
3,066 Added 7.83%
42,226 $6.08 Million
Q3 2024

Oct 29, 2024
SELL
$119.79 - $167.35 $721,734 - $1.01 Million
-6,025 Reduced 13.33%
39,160 $5.38 Million
Q2 2024

Jul 31, 2024
BUY
$120.0 - $182.95 $48,480 - $73,911
404 Added 0.9%
45,185 $5.7 Million
Q1 2024

Apr 30, 2024
SELL
$170.78 - $208.42 $299,718 - $365,777
-1,755 Reduced 3.77%
44,781 $8.24 Million
Q4 2023

Feb 05, 2024
SELL
$114.17 - $185.35 $915,186 - $1.49 Million
-8,016 Reduced 14.69%
46,536 $8.37 Million
Q3 2023

Nov 08, 2023
SELL
$138.78 - $176.51 $223,574 - $284,357
-1,611 Reduced 2.87%
54,552 $8.68 Million
Q2 2023

Aug 03, 2023
SELL
$138.42 - $180.31 $642,822 - $837,359
-4,644 Reduced 7.64%
56,163 $7.94 Million
Q1 2023

May 03, 2023
SELL
$154.26 - $198.1 $648,817 - $833,208
-4,206 Reduced 6.47%
60,807 $10.2 Million
Q4 2022

Feb 08, 2023
BUY
$162.42 - $220.56 $2.71 Million - $3.67 Million
16,660 Added 34.45%
65,013 $11 Million
Q3 2022

Oct 27, 2022
BUY
$160.42 - $256.21 $6.82 Million - $10.9 Million
42,506 Added 726.97%
48,353 $9.05 Million
Q2 2022

Aug 03, 2022
SELL
$140.68 - $188.02 $91,160 - $121,836
-648 Reduced 9.98%
5,847 $950,000
Q1 2022

May 10, 2022
BUY
$161.19 - $257.96 $390,402 - $624,779
2,422 Added 59.46%
6,495 $1.22 Million
Q4 2021

Jan 26, 2022
BUY
$247.59 - $304.47 $157,467 - $193,642
636 Added 18.5%
4,073 $1.08 Million
Q3 2021

Nov 03, 2021
SELL
$194.77 - $324.21 $3,116 - $5,187
-16 Reduced 0.46%
3,437 $993,000
Q2 2021

Aug 10, 2021
BUY
$165.87 - $220.95 $22,724 - $30,270
137 Added 4.13%
3,453 $689,000
Q1 2021

May 13, 2021
BUY
$180.37 - $226.26 $598,106 - $750,278
3,316 New
3,316 $645,000

Others Institutions Holding RGEN

# of Institutions
479
Shares Held
54.5M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $9.22B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Van Eck Associates Corp Portfolio

Follow Van Eck Associates Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email